Eric Aboagye is Professor of Cancer Pharmacology & Molecular Imaging and Director of the CRUK-EPSRC-MRC-NIHR Comprehensive Cancer Imaging Centre. He joined the college after a PhD at the CRUK Beatson Laboratories in Glasgow, UK and post-doc fellowship at The Johns Hopkins University & Hospital in Baltimore, USA. His group is interested in the discovery and development of new methods for experimental and clinical cancer molecular imaging. In the past 5 years, the team has invented and translated three novel cancer diagnostics into human application. He has acted as an advisor to GE-Healthcare, GSK, Roche and Novartis.
Professor Aboagye was recipient of the 2009 Sir Mackenzie Davidson Medal and was elected as a Fellow of the Academy of Medical Sciences in 2010. Academy Fellows are elected for outstanding contributions to the advancement of medical science, for innovative application of scientific knowledge or for conspicuous service to healthcare.
et al., 2020, Radio- and nano-chemistry of aqueous Ga(iii) ions anchored onto graphene oxide-modified complexes., Nanoscale
et al., Clinical Translation of 18F-Fluoropivalate - A PET Tracer for Imaging Short-Chain Fatty Acid Metabolism: Safety, Biodistribution, and Dosimetry in Fed and Fasted Healthy Volunteers, European Journal of Nuclear Medicine and Molecular Imaging, ISSN:1619-7070
et al., Lactic acidosis induces resistance to the pan-Akt inhibitor uprosertib in colon cancer cells, British Journal of Cancer, ISSN:0007-0920
et al., A novel approach to imaging active Takayasu arteritis using somatostatin receptor PET/MRI ligands, Circulation: Cardiovascular Imaging, ISSN:1941-9651
et al., 2019, One-pot radiosynthesis and biological evaluation of a caspase-3 selective 5-[(123,)(125) I]iodo-1,2,3-triazole derived satin SPECT tracer, Scientific Reports, Vol:9, ISSN:2045-2322